netFormulary NHS
Southampton Joint Formulary
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.01  Drugs used in rheumatic diseases and gout
10.01.01  Non-steroidal anti-inflammatory drugs
Ibuprofen
(tablet/liquid)
View adult BNF View SPC online View childrens BNF
First Choice
Green

A first line NSAID, except for gout

 
Naproxen
(tablet)
View adult BNF View SPC online View childrens BNF
First Choice
Green

A first line NSAID

 
Celecoxib
(capsules)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Diclofenac
(tablet/MR tablet/dispersible tablet/suppositories)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Not a first line NSAID

 
Link  Diclofenac MHRA safety update 2013
   
Diclofenac 50mg in 5ml
(oral suspension)
View adult BNF View childrens BNF
Formulary
Red

Restricted Item unlicensed Unlicensed special. Restricted use - short term use for postoperative analgesia in children. Second line to ibuprofen and only when licensed options are not suitable. 

 
   
Diclofenac with misoprostol (Arthrotec®)
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Diclofenac not a first line NSAID.

Consider using a preferred NSAID (e.g. ibuprofen or naproxen) or celecoxib ± gastroprotection (e.g. PPI) as alternative

 
   
Etoricoxib (Arcoxia®)
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Recommended
 
   
Ibuprofen
(soluble (Melt) tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
   
Indometacin
(capsule/MR capsule/suppositories/liquid)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Not a first line NSAID

unlicensed Liquid is unlicensed

 
   
Meloxicam
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Blue

Restricted Item Existing patients only.

 
   
Nabumetone
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Not a first line NSAID

 
   
Phenylbutazone
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Initiation

Restricted Item Specialist use only

 
   
Mefenamic Acid
(tablet)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Green

Not a first line NSAID.

For dysmenorrhoea and menorrhagia only, but no evidence to support superiority vs other NSAIDs, and safety concerns in overdose. Use only if preferred NSAIDs (naproxen or ibuprofen) not suitable.

 
   
10.01.02  Corticosteroids
10.01.02.01  Systemic corticosteroids
Prednisolone
(tablet/soluble tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Not EC tablet

 
   
10.01.02.02  Local corticosteroids injections to top
Hydrocortisone acetate (Hydrocortistab®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Methylprednisolone Acetate (Depo-Medrone®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Methylprednisolone Acetate (Depo-Medrone® with Lidocaine)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Pelvic pain clinic

 
   
Triamcinolone Acetonide
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Adcortyl or Kenalog depending on volume

 
   
Triamcinolone hexacetonide
(injection)
Formulary
Red

Restricted Item For paediatric rheumatology

 
   
10.01.03  Drugs which suppress the rheumatic disease process
10.01.03  Gold
Soldium Aurothiomalate (Myocrisin®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG
 
Link  Gold shared care guideline available here
   
10.01.03  Penicillamine
Penicillamine
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Initiation
 
   
10.01.03  Antimalarials
Hydroxychloroquine
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG

Restricted Item Supported only for indications detailed in Shared Care Guidelines.

Not for use in Covid-19 treatment/prevention outside of clinical trials (see links below). Seek further advice from infection control specialist/pharmacy team.

 
Link  DPC Hydroxychloroquine Shared Care Guideline May 2017
Link  EMA statement: COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes April 2020
Link  MHRA Advice March 2020: Do not use hydroxychlorquine or chloroquine for Covid-19 treatment except within a clinical trial
Link  NHS England/UK Chief Medical Officers’ joint letter: Novel coronavirus: clinical trials April 2020
Link  NPA Advice for Pharmacists on sales or supply of chloroquine/hydroxychloroquine for Covid-19 treatment/prevention
   
10.01.03  Drugs affecting the immune response to top
Anakinra (Kineret®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Restricted Item Restricted as per commissioning policies. 

 
   
Cytotoxic Drug Azathioprine
(tablet/capsules/liquid)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG

unlicensed Liquid and capsules (10mg) are unlicensed

 
Link  Shared care guideline available here
   
BaricitinibBlack Triangle (Olumiant®)
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA466: Baricitinib for moderate to severe rheumatoid arthritis
   
Ciclosporin
(capsule/liquid)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG

Specify brand

 
Link  Shared care guideline available here
   
Leflunomide
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG
 
Link  Shared care guideline available here
   
Cytotoxic Drug Methotrexate (Rheumatology)
(tablet/subcutaneous injection)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG

ONCE WEEKLY

Restricted Item Specialist initiation (unless GP indicates preference to initiate therapy)

 
Link  Shared care guideline available here
   
10.01.03  Cytokine modulators
Abatacept (Orencia®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor
Link  NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
   
Adalimumab/ adalimumab biosimilar (Humira®, Imraldi®, Amgevita® ) (Rheumatology)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Specify brand

Imraldi and Amgevita are black triangle

 
Link  NICE TA195: Rheumatoid arthritis - after failure of a TNF inhibitor
Link  NICE TA199: Psoriatic arthritis
Link  NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
ApremilastBlack Triangle
(tab)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA455: Apremilast for active psoriatic arthritis
   
BelimumabBlack Triangle (Benlysta® )
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA397: Belimumab for treating active autoantibody-positive systemic lupus erythematosus
   
Certolizumab Pegol (Cimzia®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
Link  NICE TA415: Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor
Link  NICE TA445 : Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARD
   
Etanercept/etanercept biosimilar (Enbrel®, Benepali®, Erelzi®) (Rheumatology)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

note Specify brand

Erelzi is black triangle

 
Link  NICE TA195: Rheumatoid arthritis after the failure of a TNF inhibitor
Link  NICE TA199: Psoriatic arthritis
Link  NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for JIA
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
Golimumab (Simponi®) (Rheumatology)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA220: Golimumab for the treatment of psoriatic arthritis
Link  NICE TA497: Golimumab for treating non-radiographic axial spondyloarthritis
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
Infliximab/infliximab biosimilar (rheumatology)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

note Specify brand (e.g. Remicade®, Remsima®, Inflectra®, Flixabi®, Zessly®)

 

 
Link  NICE TA195: Rheumatoid arthritis (after failure of a TNF inhibitor)
Link  NICE TA199: Psoriatic arthritis
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
IxekizumabBlack Triangle (Taltz®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  TA537: Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs
   
Rituximab/rituximab biosimilar (MabThera®, Rixathon®, Truxima®) (Rheumatology & Other)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England

Also for pemphigus vulgaris (MabThera brand only).

unlicensed off label use in pemphigoid; nephrotic syndrome (children); systemic lupus erythematosus in adults/post-pubescent children; anti-NMDAR autoimmune encephalitis (all ages); immunoglobulin G4-related disease.

Not NHS Not routinely commissioned for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), multifocal motor neuropathy (MMN), vasculitis of the peripheral nervous system & IgM paraprotein-associated demyelinating neuropathy (adults) or for connective tissue disease associated with interstitial lung disease - see NHS England Commissioning Policies.

note Specify brand

Rixathon and Truxima black triangle

 

 
Link  NHS England Clinical Commissioning Policy: Rituximab for CIDP, MMN, vasculitis of the peripheral nervous system & IgM paraprotein-associated demyelinating neuropathy (adults)
Link  NHS England Clinical Commissioning Policy: Rituximab for connective tissue disease associated with interstitial lung disease
Link  NHS England Clinical Commissioning Policy: Rituximab for immunoglobulin G4-related disease
Link  NHS England Clinical Commissioning Policy: Rituximab for refractory SLE in adults and post-pubescent children
Link  NHS England Clinical Commissioning Policy: Rituximab for second line treatment for anti-NMDAR autoimmune encephalitis (all ages)
Link  NHS England Clinical Commissioning Policy: Rituximab for the treatment of ANCA-associated vasculitis in adults
Link  NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor
Link  NICE TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
   
Sarilumab (Kevzara®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA485:Sarilumab for moderate to severe rheumatoid arthritis
   
SecukinumabBlack Triangle (Cosentyx®) (Rheumatology)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Rheumatology indications

 
Link  NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors
Link  NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs
   
Tocilizumab (RoActemra®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

unlicensed Also used off-label for toxicities associated with CAR-T cell therapy

 

Restricted Item Not for use in Covid-19 treatment outside of clinical trials. Seek further advice from infection control specialist/pharmacy team.

 
Link  NHS England/UK Chief Medical Officers’ joint letter: Novel coronavirus: clinical trials April 2020
Link  NICE TA247: Tocilizumab for the treatment of rheumatoid arthritis
Link  NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
Link  NICE TA375: Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
Link  NICE TA518:Tocilizumab for treating giant cell arteritis
   
Tofacitinib (XELJANZ®)
(tablets)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA480: Tofacitinib for moderate to severe rheumatoid arthritis
Link  NICE TA543: Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs
   
10.01.03  Sulfasalazine
Sulfasalazine EC (Salazopyrin EN-Tabs®) (Rheumatology)
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG
 
Link  Shared care guideline available here
   
10.01.04  Gout and cytotoxic-induced hyperuricaemia
10.01.04  Acute attacks of gout
 note 

NSAIDs (not aspirin)  - see section 10.1.1

Colchicine
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Second line

 
   
10.01.04  Long-term control of gout to top
Allopurinol
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Febuxostat (Adenuric® )
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  NICE TA164: Febuxostat for the management of hyperuricaemia in people with gout
   
10.01.04  Hyperuricaemia associated with cytotoxic drugs
Rasburicase (Fastertec®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Oncology only

 
   
10.01.05  Other drugs for rheumatic diseases
10.02  Drugs used in neuromuscular disorders
AtalurenBlack Triangle (Translarna®)
(granules)
View adult BNF View SPC online View childrens BNF
Formulary
Red Specialist Centre
High Cost Medicine
NHS England
BlueTeq

For use in line with NHSE specialised commissioning criteria

 
Link  NICE HST3: Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
   
Cladribine (Mavenclad®)
(tablets)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England
 
Link  NICE TA616: Cladribine for treating relapsing–remitting multiple sclerosis
   
NusinersenBlack Triangle (Spinraza ®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

For use in spinal muscular atrophy (SMA) in line with NHSE specialised commissioning criteria

 

 
Link  Clinical Commissioning Policy Statement: Nusinersen for genetically confirmed Spinal Muscular Atrophy (SMA) type 1 for eligible patients under the Expanded Access Programme (EAP)
Link  NICE TA588: Nusinersen for treating spinal muscular atrophy
   
RisdiplamBlack Triangle
(Powder for oral suspension)
Formulary
Red
High Cost Medicine
NHS England
Homecare
BlueTeq

Restricted Item For the treatment of type 1 and type 2 Spinal Muscular Atrophy (SMA) in patients 2 months and older who are not suitable for authorised treatments.

Specialist use only.

Available via MHRA EAMS application for eligible patients.

EAMS available here

 
   
10.02.01  Drugs which enhance neuromuscular transmission
10.02.01  Anticholinesterases to top
Neostigmine
(tablet/injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
   
Pyridostigmine Bromide
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Initiation
 
   
10.02.01  Acetylcholine-release enhancers
Amifampridine base (3,4-diaminopyridine)
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

unlicensed unlicensed

For Lambert-Eaton myasthenic Syndrome

 
   
10.02.02  Skeletal muscle relaxants
Baclofen
(tablet/liquid)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Controlled Drug Cannabis extract (Sativex®)
(oromucosal spray)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Restricted Item Restricted use.

Use is supported only for spasticity in patients with multiple sclerosis in accordance with NICE guidelines NG144.

Must be initiated and supervised by a physician with specialist expertise in treating spasticity due to multiple sclerosis.

For secondary care prescribing only until shared care guidelines have been developed and approved.

 
Link  NICE Guidelines NG144 Cannabis-based medicinal products Nov 2019
Link  SHIP8 Priorities Committee Policy Recommendation: Sativex for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis
   
Dantrolene
(capsule)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Diazepam
(tablet/liquid/injection/rectal liquid)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Mexiletine (Namuscla®)
(capsules - myotonia)
View adult BNF View SPC online View childrens BNF
Formulary
Red Specialist Centre
High Cost Medicine
NHS England
BlueTeq

 Commissioned by NHS England for patients with non-dystrophic myotonia within specialised neurosciences centres only

note Note: mexiletine also approved locally as amber for cardiology use only (see section 2.3.2).

(167mg mexiletine = 200mg mexiletine hydrochloride)

 
Link  NHS England Letter confirming commissioning arrangements for NaMuscla April 2019
   
Tizanidine
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Recommended
 
   
10.02.02  Other muscle relaxants
10.02.02  Nocturnal leg cramps
Quinine sulfate
(tablet)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
10.03  Drugs for the treatment of soft-tissue disorders and topical pain relief to top
10.03  Extravasation
10.03.01  Enzymes
Collagenase (Xiapex®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Limited usage - contact Care Group Pharmacist

 
Link  NICE TA459 : Collagenase clostridium histolyticum for treating Dupuytren’s contracture
   
10.03.02  Rubefacients, topical NSAIDs, capsaicin, and poultices
10.03.02  Topical NSAIDs and counter-irritants
Diethylamine salicylate (Algesal®)
(cream)
View adult BNF View SPC online View childrens BNF
Formulary
Blue

Self Care Self Care Medicine

 
   
Ibuprofen 5%
(gel)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Self Care Self Care Medicine

 
   
Transvasin®
(cream)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Restricted Item For use in the respiratory centre only, prior to capillary blood gas sampling

Contains: Tetrahydrofurfuryl salicylate 14%, ethyl nicotinate 2%, hexyl nicotinate 2%

 
   
10.03.02  Capsaicin to top
Capsaicin (Qutenza®)
(patch)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Restricted Item Only for post herpetic neuralgia where other pain relief is inadequate

 
   
Capsaicin 0.025% (Zacin®)
(cream)
View adult BNF View SPC online View childrens BNF
Formulary
Blue
 
   
 ....
 Non Formulary Items
Auranofin  (Ridaura®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Betamethasone  (Betnesol®)
(injection - local)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Capsaicin 0.075%  (Axsain ®)
(cream)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Dexamethasone
(joint injection)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Diclofenac
(gel)

View adult BNF View SPC online View childrens BNF
Non Formulary

Self Care Self Care Medicine

 
Distigmine Bromide

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Edrophonium Chloride

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Etodolac
(caps/MR tabs)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Felbinac  (Traxam®)
(gel/foam)

View adult BNF View SPC online View childrens BNF
Non Formulary

Self Care Self Care Medicine

 
Glucosamine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Hyaluronidase  (Hyalase®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ibuprofen 10%
(gel)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Infliximab biosimilar  (Remsima®)
(pre-filled syringe/pen for SC injection)

View adult BNF View SPC online View childrens BNF
Non Formulary

For subcutaneous injection.

Black Non-formulary for all indications while awaiting commissioning decisions.

Link  NICE ES29: Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
 
Ketoprofen
(caps/MR caps)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ketoprofen 2.5%  (Oruvail ®, Powergel®)
(gel)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lesinurad  (Zurampic®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Methocarbamol  (Robaxin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Movelat®
(gel / cream)

View adult BNF View SPC online View childrens BNF
Non Formulary

Self Care Self Care Medicine

Contains: Mucopolysaccharide polysulfate 0.2%, salicylic acid 2% 

 
Piroxicam 2.5%  (Feldene®)
(gel)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Prednisolone Acetate  (Deltastab®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Probenecid

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sulfinpyrazone

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine

Traffic Light Status Information

Status Description

Green

Suitable for prescribing by all in both primary and secondary care.  

Amber Recommended

Specialist recommended but suitable for continuation in primary care.  

Amber Initiation

Specialist initiated but suitable for continuation in primary care.  

Amber SCG

Specialist initiated and for continuation in primary care under a locally approved shared care guideline.  

Red

Suitable for prescribing in specialist settings (secondary care) only.   

Red Specialist Centre

Secondary care medicines to be used under specialised commissioning arrangements only.  

Blue

For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy.  

Black

Not recommended for use.  

netFormulary